TENAX THERAPEUTICS, INC. Employee-related Liabilities
TENAX THERAPEUTICS, INC. (TENX) had Employee-related Liabilities of $571.40 thousand as of 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent · last filed 2019-04-01
- 2018-12-31: Employee-related Liabilities $571.40K.
- 2018-09-30: Employee-related Liabilities $47.95K.
- 2018-06-30: Employee-related Liabilities $442.32K.
- 2018-03-31: Employee-related Liabilities $52.18K.
| Period end | Employee-related Liabilities |
|---|---|
| 2018-12-31 | $571.40K 10-K · filed 2019-04-01 |
| 2018-09-30 | $47.95K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $442.32K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $52.18K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $324.05K 10-K · filed 2019-04-01 |
| 2017-09-30 | $52.38K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $69.35K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $69.63K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $884.01K 10-K · filed 2018-04-02 |
| 2016-09-30 | $83.93K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $79.50K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $76.72K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $545.72K 10-K · filed 2017-03-16 |
| 2015-10-31 | $81.92K 10-Q · filed 2015-12-10 |
| 2015-07-31 | $106.93K 10-Q · filed 2015-09-09 |
| 2015-04-30 | $596.14K 10-KT · filed 2016-03-14 |
| 2015-01-31 | $46.39K 10-Q · filed 2015-03-17 |
| 2014-10-31 | $286.84K 10-Q · filed 2014-12-15 |
| 2014-07-31 | $64.22K 10-Q · filed 2014-09-15 |
| 2014-04-30 | $609.13K 10-KT · filed 2016-03-14 |
| 2014-01-31 | $220.07K 10-Q · filed 2014-03-17 |
| 2013-10-31 | $92.06K 10-Q · filed 2013-12-17 |
| 2013-07-31 | $95.05K 10-Q · filed 2013-09-17 |
| 2013-04-30 | $66.63K 10-K · filed 2014-07-29 |
| 2013-01-31 | $77.32K 10-Q · filed 2013-03-18 |
| 2012-10-31 | $54.81K 10-Q · filed 2012-12-14 |
| 2012-07-31 | $215.67K 10-Q · filed 2012-09-19 |
| 2012-04-30 | $352.40K 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |